UniSA Professor Richard D'Andrea and Associate Professor Lisa Ebert in the new lab.A new tissue culture facility has opened at UniSA today, helping to ...

AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

A retrospective analysis showed improved overall survival (OS) with Orca-T compared with post-transplant cyclophosphamide in ...

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce David L. Porter, MD, as the ...

Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of ...

At that stage, the only hope for remission is through immunotherapy ... influence responses to cellular therapy, raising the question: why do some patients benefit from immunotherapy while ...